Physician profile

Peter Theoharidis

Oral and Maxillofacial Pathology · South Yarmouth, MA

NPI 1831176494

$3,241.67

in general payments reported to CMS, 2019-2025

6 companies · $419 in 2025

The $419 reported for 2025 was more than what 80% of Oral and Maxillofacial Pathology providers received nationally (typical 2025 total: $90.97).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,142.86
Entertainment$147.05
Gift$136.60

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Zimvie INC. $1,482.16 2022-2025
Zimmer Biomet Holdings, INC. $933.94 2019-2021
Southern Implants North America INC $385.99 2019-2021
Keystone Dental INC. $303.43 2019-2023
Novo Nordisk INC $123.59 2021
Ace Surgical Supply Co., INC. $12.56 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Peter Theoharidis

$3,241.67

in general payments reported 2019-2025

Years
2019-2025
Top company
Zimvie INC.
Context
The $419 reported for 2025 was more than what 80% of Oral and Maxillofacial Pathology providers received nationally (typical 2025 total: $90.97).

https://glasscript.com/doctor/1268840/peter-theoharidis

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.